Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared?
暂无分享,去创建一个
[1] R. Emerson,et al. Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade , 2018, Cancer Immunology Research.
[2] B. Coventry,et al. Isolated Limb Infusion for Recurrent and Locally Metastatic Limb Melanoma , 2018 .
[3] B. Coventry,et al. Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study , 2017, Annals of Surgical Oncology.
[4] M. Wouters,et al. Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients , 2017, Annals of Surgical Oncology.
[5] Lesly A. Dossett,et al. Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma , 2016, Annals of Surgical Oncology.
[6] C. Verhoef,et al. Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[7] A. Testori,et al. Local and intralesional therapy of in‐transit melanoma metastases , 2011, Journal of surgical oncology.
[8] C. Augustine,et al. Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution. , 2011, Journal of the American College of Surgeons.
[9] P. Kam,et al. Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. , 2011, Current problems in surgery.
[10] L. de la Cruz-Merino,et al. Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. , 2010, The oncologist.
[11] R. Petersen,et al. Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion , 2008, Annals of Surgical Oncology.
[12] P. Kam,et al. Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience , 2008, Annals of Surgical Oncology.
[13] J. Zager,et al. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[14] B. Etten,et al. Fifty Tumor Necrosis Factor–Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors , 2003, Annals of Surgical Oncology.
[15] A. Eggermont,et al. Systemic toxicity after isolated limb perfusion with melphalan for melanoma. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.